These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2295809)

  • 1. Idiotypic variation in a human B lymphoma cell line.
    Berinstein N; Campbell MJ; Lam K; Carswell C; Levy S; Levy R
    J Immunol; 1990 Jan; 144(2):752-8. PubMed ID: 2295809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal diversity in human B cell lymphoma. I. Idiotypic and genetic analysis of lymphoma heterohybrids.
    Rudders RA; Jespersen DL; Zacks J; Sikorski A; DeLellis RA; Krontiris T
    J Immunol; 1990 Jan; 144(1):396-407. PubMed ID: 2104893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B cell lymphoma.
    Weiner GJ; Kaminski MS
    J Immunol; 1990 Mar; 144(6):2436-45. PubMed ID: 1690244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma.
    Weiner GJ; Kaminski MS
    J Immunol; 1989 Jan; 142(1):343-51. PubMed ID: 2783325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants.
    Starnes CO; Carroll WL; Campbell MJ; Houston LL; Apell G; Levy R
    J Immunol; 1988 Jul; 141(1):333-9. PubMed ID: 3132505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of anti-idiotype antibody-resistant variants of a murine B cell lymphoma.
    Roth MS; Weiner GJ; Allen EA; Terry VH; Harnden CE; Boehnke M; Kaminski MS; Ginsburg D
    J Immunol; 1990 Jul; 145(2):768-77. PubMed ID: 2114449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas.
    Thielemans K; Maloney DG; Meeker T; Fujimoto J; Doss C; Warnke RA; Bindl J; Gralow J; Miller RA; Levy R
    J Immunol; 1984 Jul; 133(1):495-501. PubMed ID: 6609992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies.
    Meeker T; Lowder J; Cleary ML; Stewart S; Warnke R; Sklar J; Levy R
    N Engl J Med; 1985 Jun; 312(26):1658-65. PubMed ID: 3923352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of anti-idiotypic T cell lines propagated with syngeneic B lymphocytes. I. T cells bind intact idiotypes and discriminate between the somatic idiotypic variants in a manner similar to the anti-idiotopic antibodies.
    Cerny J; Smith JS; Webb C; Tucker PW
    J Immunol; 1988 Dec; 141(11):3718-25. PubMed ID: 3263431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics.
    George AJ; Spellerberg MB; Stevenson FK
    J Immunol; 1988 Mar; 140(5):1695-701. PubMed ID: 3162250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of an idiotype+ B cell lymphoma. Effects of antigen and anti-idiotopic antibodies on proliferation and Ig secretion.
    Ward RE; McNamara-Ward M; Webb CF; Altman D; Lim PL; Tucker PW; Kohler H
    J Immunol; 1988 Jul; 141(1):340-6. PubMed ID: 3259969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined V(L)/V(H) determinants.
    Benvenuti F; Burrone OR
    Gene Ther; 2001 Oct; 8(20):1555-61. PubMed ID: 11704816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype.
    Raffeld M; Neckers L; Longo DL; Cossman J
    N Engl J Med; 1985 Jun; 312(26):1653-8. PubMed ID: 3923351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulated recombination-activating gene expression in sIg- variants of a human mature B cell line undergoing secondary Ig lambda rearrangements in cell culture.
    Stiernholm NB; Berinstein NL
    Eur J Immunol; 1993 Jul; 23(7):1501-7. PubMed ID: 8325326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of somatic variants of a B cell hybrid mediated by a non-cytolytic L3T4+ idiotype-specific T cell.
    Ghosh SK; Bankert RB
    J Immunol; 1989 Jan; 142(2):409-15. PubMed ID: 2463306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of surface-bound antibody accompanying the anti-complementary modulation of leukemic B cell immunoglobulin: contrasting effects of antibodies directed against idiotypic and constant regions.
    Gordon J; Anderson VA; Stevenson GT
    J Immunol; 1982 Jun; 128(6):2863-9. PubMed ID: 6804570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiotypic determinants on human T cells and modulation of human T cell responses by anti-idiotypic antibodies.
    Geha RS
    J Immunol; 1984 Oct; 133(4):1846-51. PubMed ID: 6206140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-idiotypic therapy of leukemias and lymphomas.
    Stevenson FK; George AJ; Glennie MJ
    Chem Immunol; 1990; 48():126-66. PubMed ID: 2403803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.